Anogenital cancers testing in Ripalta Cremasca

Find health labs to test for Anogenital cancers in Ripalta Cremasca and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Via San Giacomo, 19, 26900 Lodi LO, Italia

9.2 km

Unverified

See Details

Pap Smear by Synlab

Piazza Santa Cabrini, 7, 26841 Casalpusterlengo LO, Italia

11.1 km

Unverified

See Details

Pap Smear by Synlab

Circonvallazione 25 Aprile, 1, 24043 Caravaggio BG, Italia

11.4 km

Unverified

See Details

Pap Smear by Synlab

Via Camillo Benso di Cavour, 43, 25034 Orzinuovi BS, Italia

12.1 km

Unverified

See Details

Pap Smear by Synlab

Via Balilla, 66, 24058 Romano di Lombardia BG, Italia

13.1 km

Unverified

See Details

Pap Smear by Synlab

Piazzale Insurrezione, 6, 24047 Treviglio BG, Italia

13.7 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Piazza della Vittoria, 2 20020 Arese (MI)

14.9 km

Unverified

See Details

Pap Smear by Synlab

Via Paullo, 12, 20067 Tribiano MI, Italia

16.4 km

Unverified

See Details

Pap Smear by Synlab

Via Castello, 1, 24057 Martinengo BG, Italia

16.7 km

Unverified

See Details

Pap Smear by Synlab

Via Milano, 16, 25032 Chiari BS, Italia

18.1 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.